Eversept Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1M Buy
143,546
+68,838
+92% +$17.3M 1.59% 18
2025
Q4
$21.2M Buy
74,708
+29,104
+64% +$9.1M 1.07% 24
2025
Q3
$14.1M Buy
+45,604
New +$14.3M 0.97% 25
2023
Q4
Sell
-21,299
Closed -$3.4M 68
2023
Q3
$3.4M Buy
+21,299
New +$4.77M 0.29% 55
2022
Q1
Sell
-30,172
Closed -$8.03M 103
2021
Q4
$8.03M Buy
+30,172
New +$8.75M 0.51% 50
2018
Q4
Sell
-8,765
Closed -$929K 62
2018
Q3
$929K Buy
+8,765
New +$821K 0.41% 37

Other funds holding PODD

Eversept Partners's PODD Position: Q1 2026 in Review

Eversept Partners increased its Insulet (PODD) stake by 92% in Q1 2026, buying an estimated $17.3M and bringing the position to 143,546 shares worth $30.1M. The position accounts for 1.59% of the portfolio, ranked #18.

Eversept Partners first reported a position in PODD in Q3 2018 and has held it in 6 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Eversept Partners held 143,546 shares of Insulet worth $30.1M as of Q1 2026.
  • Eversept Partners bought 68,838 Insulet shares in Q1 2026, an estimated $17.3M.
  • Insulet made up 1.59% of Eversept Partners's portfolio in Q1 2026, its #18 holding.
  • Eversept Partners first reported a position in Insulet in Q3 2018 and has held it in 6 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.